XOMA to Present at the Rodman and Renshaw 19th Annual Global Investment Conference
September 06 2017 - 07:00AM
XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and
development of therapeutic antibodies, today announced that Jim
Neal, Chief Executive Officer, will present the Company’s strategic
initiatives and value drivers at the Rodman and Renshaw 19th Annual
Global Investment Conference on Tuesday, September 12, 2017, at
8:45 a.m. ET. The conference is being held at the Lotte New York
Palace Hotel in New York City.
A live audio webcast of the presentation can be accessed in the
Investors section of XOMA's website at www.xoma.com. An
archived version of the webcast will be available via replay for 90
days following the presentation.
About XOMA Corporation
XOMA has an extensive portfolio of products, programs, and
technologies that are the subject of licenses the Company has in
place with other biotech and pharmaceutical companies. Many
of these licenses are the result of the Company's pioneering
efforts in the discovery and development of antibody therapeutics.
There are more than 20 such programs that are fully funded by
partners and could produce milestone payments and royalty payments
in the future. For more information, visit www.xoma.com.
Forward-Looking Statements
Certain statements contained in this press
release are forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, including statements regarding the
potential of XOMA’s portfolio of partnered programs and licensed
technologies generating substantial milestone and royalty proceeds
over time. These statements are based on assumptions that may not
prove accurate, and actual results could differ materially from
those anticipated due to certain risks inherent in the
biotechnology industry and for companies engaged in the development
of new products in a regulated market. Potential risks to XOMA
meeting these expectations are described in more detail in XOMA's
most recent filing on Form 10-K and in other SEC filings. Consider
such risks carefully when considering XOMA's prospects. Any
forward-looking statement in this press release represents XOMA's
views only as of the date of this press release and should not be
relied upon as representing its views as of any subsequent date.
XOMA disclaims any obligation to update any forward-looking
statement, except as required by applicable law.
Investor contact:
Luke Heagle
Pure Communications, Inc.
+1 910-726-1372
lheagle@purecommunications.com
Media contact:
Colin Sanford
Pure Communications, Inc.
+1 415-946-1094
csanford@purecommunications.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Feb 2024 to Mar 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2023 to Mar 2024